Additionally, GPC1 has been demonstrated to be specifically enriched in tumor cell-derived exosomes in pancreatic cancer, and the GPC1+ exosome was proposed as a marker for the early diagnosis of pancreatic cancer and prediction of the prognosis in pancreatic cancer patients [12]. This evidence concerns the gene GPC1 and pancreatic neoplasm.